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Have the symptoms of patients with COVID-19 changed over time during hospitalization?
Dear Editor,
Coronavirus disease 2019 (COVID-19) is an ongoing viral pandemic
that started from China in December 2019 and rapidly spread to the
other countries of the world. Iran was among the first countries,
struggled with the COVID-19 epidemic, and Saveh was among the first
cities, reporting the highest number of infected patients before March
15, 2020 [1]. There is no clear image of the spectrum of symptoms or
severity of COVID-19. Common symptoms include fever, cough,
weakness, and dyspnea. The less frequent symptoms include anorexia,
diarrhea, pharyngalgia, abdominal pain, dizziness, headache, low level
of consciousness, acute cerebrovascular disease, ataxia, neuralgia, fa-
tigue, acute respiratory distress syndrome, sore throat, arthralgia,
asthenia, rhinorrhea, sneezing, myalgia, vomiting, orbital pain, facial
pain and fullness, nasal irritation, otalgia, cephalalgia, delirium, hoarse
voice, hypogeusia, hyposmia, unilateral facial palsy, vertigo, and skin
rash [2–6]. After assessing the exclusion criteria in 500 patients with
COVID-19 (i.e., patients who were dead, lost to follow-up, or admitted
to the intensive care unit), we recruited 100 patients with COVID-19,
based on the laboratory-confirmed (reverse transcription polymerase
chain reaction, RT-PCR) diagnosis of SARS-CoV-2 infection who had
fever, dyspnea, non-productive cough, weakness, and myalgia at the
time of admission. The subjects were admitted to Shahid Modarres
Hospital in Saveh, Iran, between March 1, 2020 and April 1, 2020. We
evaluated the most common clinical manifestations of patients (based
on previous studies) during their hospitalization and one month after
discharge. Also, we recorded the average date of the onset of symptoms
from the first day of hospitalization until the 40th day, as shown in
Fig. 1. Data were collected by trained staff during the patients’ hospi-
talization and after one month. The mean age of the patients was
55 ± 11.8 years (ranged from 19 to 90 years), and the average length
of hospital stay was ten days. About 58.6% (88 persons) were males.
Treatment included oseltamivir and hydroxychloroquine, and if ne-
cessary, antibiotics were administered, according to the patient’s con-
dition. At the time of admission, all of our patients had fever, dyspnea,
non-productive cough, weakness, and myalgia. After two days of hos-
pitalization, the majority of the patients reported adding diarrhea and
anorexia. After seven days of hospitalization, more than 60% of the
patients reported olfactory and gustatory dysfunctions while they re-
covered from fever, dyspnea, myalgia, diarrhea and anorexia. Also, 80
and 70% of the patients reported continuing non-productive cough and
weakness for one month after discharge, respectively. We reported in
another study that the chief complaint of patients has changed at the
time of admission by passing the time between March 1, 2020 and May
1, 2020 [7]. Based on the present results, the clinical manifestations of
COVID-19 also have changed over time among patients during hospi-
talization. To the best of our knowledge, this is the first study, in-
vestigating the changes in each patient’s symptoms over time since
hospital admission. Further clinical studies are required to determine
the changes in the patients’ symptoms over time, as these changes may
be related to the virus spread in different parts of the body, leading to
the changes in each patient’s symptoms over time.
Fig. 1. Sankey diagram of clinical manifestations of patients (X-axis) with the onset of symptoms from the first day of hospitalization until the 40th day (Y-axis).
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